Ireland James Lennertz, Group VP and GM EUMEA for BioMarin, discusses the key highlights of the past few years for BioMarin, their unique positioning as a company offering innovative therapies for ultra-rare diseases, the main challenge he sees for BioMarin’s international operations, and his priorities for the next few years. James,…
Ireland Donal Higgins, MD of Prochem Engineering, provides an overview of their life sciences operations, the key innovations they are bringing to the industry like computational fluid dynamics (CFD), and his mission to position Prochem as the leading multi-disciplinary engineering company in the southeast of Ireland. Donal, can you give our…
Philippines Ebb Hinchliffe, Executive Director of the American Chamber of Commerce of the Philippines, discusses the Chamber’s current advocacy efforts in the country and their strategic objectives moving forward in terms of increasing the already strong business ties between the United States and the Philippines. He also discusses the potential for…
Singapore Martin Dewhurst of the Global Pharmaceuticals and Medical Products Practice at McKinsey & Company provides his view of the Asia Pacific Medtech Forum 2016 in Singapore and elaborates on the prominent trends for the industry in the region. What have been your first impressions of the MedTech Forum and your…
Switzerland Outsourcing of API synthesis has stabilized in the decade since Rohner Chem entered the pharma sector in earnest, and according to CEO Daniel Pedrett the company has reached a position where it is faster, more agile and more experienced than the internal supply organizations of many mid-sized innovators. You were…
London Among the assorted pharma CEOs and KOLs gathered at the recent Financial Times Pharmaceutical and Biotechnology Conference in London, debate raged on the pros and cons of a pure play strategy, focusing on a few key therapeutic areas, compared to a more diversified approach. If the 1990s and early 2000s, were all…
Singapore Boehringer Ingelheim’s (BI) country managing director in South East Asia and South Korea (SEASK), Gerrard McKenna characterizes the recent changes within the family-owned business as “evolutionary” in nature, while highlighting the key role that Singapore plays in capitalizing on the blossoming opportunities in the region. It seems it’s been a…
Singapore Philips general manager of Health Systems, South East Asia, Johan Vooren highlights the company’s renewed commitment to Singapore with the recent opening of their APAC Center, while detailing the qualities that make the country as such an ideal testing ground for Philips’ new telehealth program. He further elaborates on the value…
France Shedding light on the unique business model of French pharma’s most successful mid-cap. Not long ago, Laboratories Servier was considered a somewhat mysterious and opaque actor on the world pharmaceuticals stage. Privately owned, smaller and sleeker than many of its direct competitors, but nonetheless formidably successful, Servier has, for…
Slovakia The basics on the country of Slovakia: name, date of independence, geography, population, currency, language, and capital. Slovakia is well integrated into the international community, with membership of the majority of large transnational institutions. Slovakia is located at the heart of Europe, within a short flight of almost every other…
Switzerland Helsinn is a leader in cancer supportive care, and Vice Chairman and CEO Riccardo Braglia enthusiastically discusses the Group’s entrance into the field of oncology therapeutics and the launch of the new Helsinn Investment Fund. Helsinn Advanced Synthesis in Biasca is a very advanced site capable of synthesizing high…
Switzerland With over 50 years of history in Switzerland, Zambon operates in Canton Ticino one of Zambon’s two major global production centers. Swiss Market Manager Giampiero Roncoroni discusses the unique features of the Swiss market, and how a particular focus on the OTC/OTX market has been a key factor of success…
See our Cookie Privacy Policy Here